TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TP53Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data

Published:2016-07-08 Issue:9 Volume:37 Page:865-876
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Human Mutation

Author:

Bouaoun Liacine¹,Sonkin Dmitriy²,Ardin Maude³,Hollstein Monica³⁴,Byrnes Graham¹,Zavadil Jiri³,Olivier Magali³

Affiliation:

1. Group of Biostatistics; International Agency for Research on Cancer; Lyon Cedex 08 69372 France

2. Division of Cancer Treatment and Diagnosis; Biometric Research Program; National Cancer Institute; Rockville 9609 Maryland

3. Group of Molecular Mechanisms and Biomarkers; International Agency for Research on Cancer; Lyon Cedex 08 69372 France

4. Faculty of Medicine and Health; University of Leeds; Leeds LS2 9JT UK

Funder

Centre International de Recherche sur le Cancer

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Reference37 articles.

1. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families;Achatz;Cancer Lett,2007

2. A method and server for predicting damaging missense mutations;Adzhubei;Nat Methods,2010

3. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity;Barretina;Nature,2012

4. Relative frequency and morphology of cancers in carriers of germline TP53 mutations;Birch;Oncogene,2001

5. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa;Bressac;Nature,1991

Cited by 600 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells;Immunity, Inflammation and Disease;2024-09

2. p53 as a Potential Actionable Target in Myxofibrosarcoma: A Molecular and Pathologic Review of a Single-Institute Series;Laboratory Investigation;2024-08

3. Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma;JTCVS Open;2024-08

4. Somatic CpG hypermutation is associated with mismatch repair deficiency in cancer;Molecular Systems Biology;2024-07-18

5. p53 at the crossroads of tumor immunity;Nature Cancer;2024-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3